表紙
市場調查報告書

質子治療的美國市場:患者數,償付政策,在質子治療中心治療中的患者數

United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers

出版商 Renub Research 商品編碼 484586
出版日期 內容資訊 英文 147 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
質子治療的美國市場:患者數,償付政策,在質子治療中心治療中的患者數 United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers
出版日期: 2019年08月01日內容資訊: 英文 147 Pages
簡介

本報告提供美國的質子治療市場相關調查分析,顯在市場與潛在市場為對象,患者數,癌症的種類,治療中心的清單,經濟性,企業分析等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場 (顯然存在、潛在) - 美國的質子治療市場

  • 質子治療:顯然存在市場
  • 質子治療:潛在市場

第5章 患者數 - 美國的質子治療

  • 實數
  • 潛在數

第6章 癌症的種類 - 美國的質子治療的患者數

  • 中樞神經系統 (CNS) 腫瘤
  • 眼球內黑色素瘤
  • 下垂體腫瘤
  • 顱底/主軸骨骼腫瘤
  • 頭頸椎癌症
  • 肺癌症
  • 後腹膜肉瘤
  • 兒童癌症 (18歲以下)
  • 消化管癌症
  • 尿路癌症
  • 女性、骨盆內臟器癌症
  • 前列腺癌症
  • 乳癌
  • 其他

第7章 癌症的種類 - 美國的質子治療市場

  • 中樞神經系統 (CNS) 腫瘤
  • 眼球內黑色素瘤
  • 下垂體腫瘤
  • 顱底/主軸骨骼腫瘤
  • 頭頸椎癌症
  • 肺癌症
  • 後腹膜肉瘤
  • 兒童癌症 (18歲以下)
  • 消化管癌症
  • 尿路癌症
  • 女性、骨盆內臟器癌症
  • 前列腺癌症
  • 乳癌
  • 其他

第8章 美國 - 質子治療中心的清單

  • 運作中
  • 建設中
  • 計劃中

第9章 各中心 - 治療中的患者數

  • Loma Linda (LLUMC) Proton Therapy Center
  • UCSF - CNL Proton Therapy Center
  • Boston (NPTC) Proton Therapy Center
  • Bloomington (MPRI, 2) Proton Therapy Center
  • Houston (MD Anderson) Proton Therapy Center
  • UFPTI Jacksonville Proton Therapy Center
  • Oklahoma City (ProCure PTC) Proton Therapy Center
  • CDH Warrenville Proton Therapy Center
  • Philadelphia (Upenn) Proton Therapy Center
  • Hampton (HUPTI) Proton Therapy Center
  • New Jersey (ProCure PTC) Proton Therapy Center
  • Seattle (SCCA ProCure PTC) Proton Therapy Center
  • St. Louis (S. Lee King PTC) Proton Therapy Center
  • Provision Center for Proton Therapy, Knoxville, TN
  • San Diego (Scripps PTC) (2014 - 2017)
  • Shreveport (Willis Knighton) Proton Therapy Center
  • Jacksonville (Ackerman CC) Proton Therapy Center
  • Rochester (Mayo PBTC) Proton Therapy Center
  • Brunswick (Laurie PC) Proton Therapy Center
  • Irving (Texas Center for PT) Proton Therapy Center
  • Memphis (St. Jude PTC) Proton Therapy Center
  • Phoenix (Mayo PBTC) Proton Therapy Center
  • Baltimore (Maryland PTC) Proton Therapy Center
  • Cincinnati (Children's PTC) Proton Therapy Center
  • Orlando (Orlando Health PTC) Proton Therapy Center
  • Cleveland (UH Sideman PTC) Proton Therapy Center

第10章 質子治療 - 償付政策

  • 患者
  • 醫療機關、相關利益者、廠商

第11章 標準的質子治療中心的結構要素

  • 質子加速器
  • 射束傳輸系統
  • 電子束提供系統
  • 管嘴
  • 治療計劃系統
  • 影像查看器
  • 患者定位系統 (PPS)
  • 人力資源

第12章 企業分析

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

第13章 促進因素

第14章 課題

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

United States is the hub of proton therapy industry where various advanced and children specialist centers and preferential facilities are available for the child. In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase. Proton therapy centers are growing at a rapid pace in United States as its cancer incidences are raising and there are more patients eligible for treatment than actually resources available for them. Proton therapy is one of the advanced techniques of radiotherapy which produces optimal amount of radiation or pinpoint radiation to kill tumor and mitigate radiation exposure to healthy tissues or cells. The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025. But the actual market is merely 10% of the potential market due to demand-supply mismatch.

Proton therapy is a non-invasive procedure that is used for the treatment of multiple cancers like CNS Cancer, Head & Neck Cancer, Prostate Cancer, Breast Cancer and Lung Cancer etc. People across the world are looking for the non-invasive procedure because of its effectiveness and painless outcome. The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.

Besides, proton therapy can be an effective treatment for recurrent tumors. Proton therapy is one of the effective treatments for pediatric patients rather than conventional radiotherapy and surgery that include various risks and complications. Additionally, children body is prone to the re-occurrence of cancer and proton therapy plays an essential role by preventing from re-occurrence. The survival rate of proton therapy is nearly 90 percent which is far better than the traditional technique to treat cancer.

"United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" is a report published by Renub Research. In this report, we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about the list of all operational and Proton Therapy centers going to open in future; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

  • 1. Actual Market is the current market which is already present
  • 2. Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year

Patient Numbers for the Treatment of Proton Therapy in United States

In this report, we have portrayed proton therapy patients into two parts; potential patients and actual one. We have also categorized the proton therapy patient numbers on the basis of cancer type into 14 sections; Central Nervous System Tumors, Intraocular Melanomas, Pituitary Neoplasms, Base of Skull / Axial Skeleton, Head and Neck, Lung Cancers, Retroperitoneal Sarcoma, Pediatric (Up to Age 18), Gastrointestinal Tract, Urinary Tract, Female Pelvic Organs, Prostate Cancer, Breast Cancer and Other.

Proton Therapy Market for 14 Types of Cancer in United States

The proton therapy market is divided into two parts; potential proton therapy market and actual proton therapy market. This report studies the 14 cancer types proton therapy market Retroperitoneal Sarcoma, Central Nervous System Tumors, Pituitary Neoplasms, Intraocular Melanomas, Lung Cancers, Base of Skull / Axial Skeleton, Gastrointestinal Tract, Pediatric (Up to Age 18), Urinary Tract, Head and Neck, Breast Cancer, Female Pelvic Organs, Prostate Cancer, and Other.

According to Renub Research Analysis, the more patients of cancer would get proton therapy treatment in United States due to rising prevalence of cancer and an increasing number of the advanced proton therapy center. Additionally, increasing technological development in Proton therapy and increasing efficiencies will further boost the market of proton therapy in United States.

Number of Patients Treated in each Proton Therapy Center of United States

In this report, we have done a full assessment of proton therapy center of United States with their treatment capabilities and technology used. Currently, there are 31 operational centers for proton therapy in United States, and XX centers are in construction phase and XX are in planning phase. In this report we have provided complete patients number treated with proton therapy by each proton therapy center of United States.

Reimbursement Policy Insights

Here, we have done an in-depth analysis of reimbursement policies in United States. Here, we have fragmented the reimbursement policy into two parts; the first one is by patient's perspective, and the second one is by manufacturer, stakeholder and institutional perspective.

Key Companies Covered

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

United States Proton Therapy Market & Patient Numbers has been analyzed from two viewpoints

  • Actual & Potential Market
  • Actual & Potential Number of Patients Treated

14 Types of Cancer - Patient Numbers & Market

  • 1. Central Nervous System Tumors Cancer
  • 2. Pituitary Neoplasms Cancer
  • 3. Intraocular Melanomas Cancer
  • 4. Lung Cancers
  • 5. Base of Skull / Axial Skeleton Cancer
  • 6. Gastrointestinal Tract Cancer
  • 7. Pediatric (Up to Age 18) Cancer
  • 8. Urinary Tract Cancer
  • 9. Head and Neck Cancer
  • 10. Breast Cancer
  • 11. Female Pelvic Organs Cancer
  • 12. Prostate Cancer
  • 13. Retroperitoneal Sarcoma Cancer
  • 14. Other Cancer

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Potential Proton Therapy Market

5. Number of Patients - United States Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Potential Numbers

6. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2025)

  • 6.1. Central Nervous System Tumors
  • 6.2. Intraocular Melanomas Cancer
  • 6.3. Pituitary Neoplasms Cancer
  • 6.4. Base of Skull / Axial Skeleton Cancer
  • 6.5. Head and Neck Cancer
  • 6.6. Lung Cancer
  • 6.7. Retroperitoneal Sarcoma Cancer
  • 6.8. Pediatric Cancer Cases (Up to Age 18)
  • 6.9. Gastrointestinal Tract Cancer
  • 6.10. Urinary Tract Cancer
  • 6.11. By Female Pelvic Organs Cancer
  • 6.12. Prostate Cancer
  • 6.13. Breast Cancer
  • 6.14. Other Cancer

7. Cancer Types - United States Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System Tumors
  • 7.2. Intraocular Melanomas Cancer
  • 7.3. Pituitary Neoplasms Cancer
  • 7.4. Base of Skull / Axial Skeleton Cancer
  • 7.5. Head and Neck Cancer
  • 7.6. Lung Cancer
  • 7.7. Retroperitoneal Sarcoma Cancer
  • 7.8. Pediatric Cancer (Up to Age 18)
  • 7.9. Gastrointestinal Tract Cancer
  • 7.10. Urinary Tract Cancer
  • 7.11. Female Pelvic Organs Cancer
  • 7.12. Prostate Cancer
  • 7.13. Breast Cancer
  • 7.14. Other Cancer

8. United States - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers
  • 8.3. Planning Proton Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
  • 9.2. UCSF - CNL Proton Therapy Center (2008 - 2015)
  • 9.3. Boston (NPTC) Proton Therapy Center (2008 - 2016)
  • 9.4. Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
  • 9.5. Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
  • 9.6. UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
  • 9.7. Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
  • 9.8. CDH Warrenville Proton Therapy Center (2010 - 2016)
  • 9.9. Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
  • 9.10. Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
  • 9.11. New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
  • 9.12. Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
  • 9.13. St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
  • 9.14. Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
  • 9.15. San Diego (Scripps PTC) (2014 - 2017)
  • 9.16. Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
  • 9.17. Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
  • 9.18. Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
  • 9.19. Brunswick (Laurie PC) Proton Therapy Center (2015)
  • 9.20. Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
  • 9.21. Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
  • 9.22. Phoenix (Mayo PBTC) Proton Therapy Center (2016)
  • 9.23. Baltimore (Maryland PTC) Proton Therapy Center (2016)
  • 9.24. Cincinnati (Children's PTC) Proton Therapy Center (2016)
  • 9.25. Orlando (Orlando Health PTC) Proton Therapy Center (2016)
  • 9.26. Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

10. Proton Therapy - Reimbursement Policies

  • 10.1. Proton Therapy Reimbursement Policies for Patients
  • 10.2. Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

11. Components of a Standard Proton Therapy Center

  • 11.1. Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 10.2.2. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in United States

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operations Challenges

List of Figures:

  • Figure 2-1: United States - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: United States - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: United States - Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 - 2018
  • Figure 4-2: United States - Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2019 - 2025
  • Figure 4-3: United States - Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 - 2018
  • Figure 4-4: United States - Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2019 - 2025
  • Figure 4-5: United States - Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 - 2018
  • Figure 4-6: United States - Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2019 - 2025
  • Figure 4-7: United States - Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 - 2018
  • Figure 4-8: United States - Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2019 - 2025
  • Figure 4-9: United States - Proton Therapy Patient by Head and Neck Cancer (Number), 2009 - 2018
  • Figure 4-10: United States - Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2019 - 2025
  • Figure 4-11: United States - Proton Therapy Patient by Lung Cancer (Number), 2009 - 2018
  • Figure 4-12: United States - Forecast for Proton Therapy Patient by Lung Cancer (Number), 2019 - 2025
  • Figure 4-13: United States - Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 - 2018
  • Figure 4-14: United States - Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2019 - 2025
  • Figure 4-15: United States - Proton Therapy Patient by Pediatric Cancer (Number), 2009 - 2018
  • Figure 4-16: United States - Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2019 - 2025
  • Figure 4-17: United States - Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 - 2018
  • Figure 4-18: United States - Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2019 - 2025
  • Figure 4-19: United States - Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 - 2018
  • Figure 4-20: United States - Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2019 - 2025
  • Figure 4-21: United States - Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 - 2018
  • Figure 4-22: United States - Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2019 - 2025
  • Figure 4-23: United States - Proton Therapy Patient by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-24: United States - Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-25: United States - Proton Therapy Patient by Breast Cancer (Number), 2009 - 2017
  • Figure 4-26: United States - Forecast for Proton Therapy Patient by Breast Cancer (Number), 2019 - 2025
  • Figure 4-27: United States - Proton Therapy Patient by Other Cancer (Number), 2009 - 2018
  • Figure 4-28: United States - Forecast for Proton Therapy Patient by Other Cancer (Number), 2019 - 2025
  • Figure 5-1: United States - Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 - 2018
  • Figure 5-2: United States - Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2019 - 2025
  • Figure 5-3: United States - Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 - 2018
  • Figure 5-4: United States - Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2019 - 2025
  • Figure 5-5: United States - Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 - 2018
  • Figure 5-6: United States - Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2019 - 2025
  • Figure 5-7: United States - Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 - 2018
  • Figure 5-8: United States - Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2019 - 2025
  • Figure 5-9: United States - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-10: United States - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-11: United States - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-12: United States - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-13: United States - Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 - 2018
  • Figure 5-14: United States - Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2019 - 2025
  • Figure 5-15: United States - Proton Therapy Market by Pediatric Cancer (Million US$), 2009 - 2018
  • Figure 5-16: United States - Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2019 - 2025
  • Figure 5-17: United States - Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-18: United States - Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-19: United States - Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 - 2018
  • Figure 5-20: United States - Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2019 - 2025
  • Figure 5-21: United States - Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 - 2018
  • Figure 5-22: United States - Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2019 - 2025
  • Figure 5-23: United States - Proton Therapy Market by Prostate Cancer (Million US$), 2009 - 2018
  • Figure 5-24: United States - Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2019 - 2025
  • Figure 5-25: United States - Proton Therapy Market by Breast Cancer (Million US$), 2009 - 2018
  • Figure 5-26: United States - Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2019 - 2025
  • Figure 5-27: United States - Proton Therapy Market by Other Cancer (Million US$), 2009 - 2018
  • Figure 5-28: United States - Forecast for Proton Therapy Market by Other Cancer (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million US$), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue, (Million US$), 2019 - 2025
  • Figure 11-1: United States - Numbers of Patient Diagnosed With cancer (In Number), 2014 - 2018
  • Figure 11-2: United States - Forecast for Numbers of Patient Diagnosed With cancer (In Number), 2019 - 2025
Back to Top